Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HMSC- A simple breast cancer screening device -- Ignore unavailable to you. Want to Upgrade?

To: ref who wrote (35)	1/6/1998 9:39:00 AM
From: Sandra	Read Replies (1) \| Respond to of 246

Dick, News! Sandra SOURCE: HumaScan Inc. HumaScan Launches BreastAlert(TM) Differential Temperature Sensor, Product Available in Physician Offices Nationwide CRANFORD, N.J., Jan. 6 /PRNewswire/ -- HumaScan Inc. (Nasdaq: HMSC - news) announced today that on December 29, 1997 the Company commenced shipments of its BreastAlert(TM) Differential Temperature Sensor, a non-invasive, adjunctive screening device which assists in the early detection of breast disease. The shipments were made to the distribution facilities of Physician Sales & Service Inc. (Nasdaq: PSSI - news), the exclusive national distributor of BreastAlert. The product will be available in all 50 states. HumaScan's eleven regional managers are spearheading the product rollout, working with PSS's 750 sales representatives nationally. Together they are concentrating their sales efforts on gynecologists and primary care physicians, who treat the majority of women with breast disease. Donald Brounstein, President and Chief Executive Officer commented, ''We are extremely pleased with the progress we have made over the last six months, leading up to the shipments of BreastAlert in December. Early reports indicate that the response by gynecologists and family practitioners is positive. Physicians say they are excited to be able to provide women with a safe, low-cost, easy-to-use product that aids in the early detection and monitoring of breast disease.'' Richard Luciani, M.D., F.A.C.O.G., a gynecologist and member of HumaScan's Scientific Advisory Committee commented, ''BreastAlert may be particularly useful for younger women under age 50, who are more likely to have aggressive cancers, where tumor doubling times can be as short as 80 days. These women may have denser breast tissue, making tumors more difficult to detect by palpation during the clinical breast exam.'' Dr. Luciani added, ''The increase in metabolic activity caused by early-stage breast disease generates heat that can be measured at the surface by BreastAlert. Every woman should understand the early detection options now available to her. The sooner she knows, the better her chances of survival.'' HumaScan will also sponsor a national breast health program for consumers, beginning in March 1998. Actress Jill Eikenberry, Golden Globe award winner for the dramatic series L.A. Law, and also a breast cancer survivor will be featured in this campaign. Together with her husband, actor Michael Tucker, Ms. Eikenberry will participate in presentations that underscore the benefits of breast self-examination and the early detection of breast disease. Advertising for BreastAlert will appear in major professional journals as well as selected consumer health publications throughout 1998. The BreastAlert DTS is a non-invasive, adjunctive screening device for the early detection of breast disease to be used by primary care physicians, gynecologists and other medical specialists. It is used at the time of clinical breast examination to detect temperature differences between the breasts which may indicate the presence of breast disease, including breast cancer. This release contains forward-looking information, including statements regarding the positive impact that this adjunctive product may have in assisting physicians in the early detection of breast disease in women. Additional information on factors that could potentially affect the Company's financial results may be found in the Company's filings with the Securities and Exchange Commission. To receive additional information on HumaScan Inc., via fax, at no charge, dial 1-800-PR0-INFO and enter code HMSC. SOURCE: HumaScan Inc. More Quotes and News: HumaScan Inc (Nasdaq:HMSC - news) Physician Sale